| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Neurology (Drs. Walter, Probst, Benecke, and Dressler), Rostock University, and Department of Neurology (Drs. Niehaus and Meyer), Charité Campus Virchow Klinikum, Humboldt University, Berlin, Germany.
Address correspondence and reprint requests to Dr. Uwe Walter, Department of Neurology, Rostock University, Gehlsheimer Str. 20, D-18147 Rostock, Germany; e-mail: uwe.walter{at}med.uni-rostock.de
Objective: To study the use of brain parenchyma sonography (BPS) in discriminating between patients with idiopathic PD (IPD) and atypical parkinsonian syndromes (APS).
Methods: Twenty-five patients with APS, 9 with progressive supranuclear palsy (PSP) and 16 with multiple-system atrophy (MSA), and 25 age-matched patients with IPD were prospectively studied with BPS according to a standardized protocol.
Results: Twenty-four of the 25 (96%) IPD patients exhibited hyperechogenicity of the substantia nigra (SN) but only 2 of 23 (9%) APS patients (Mann–Whitney U test, p < 0.001). In those two APS patients, SN hyperechogenicity was moderate only, whereas the remaining 21 APS patients had normal SN echogenicity. The specificity of SN hyperechogenicity in detection of clinically diagnosed IPD patients was 96%, and the sensitivity was 91%. If SN hyperechogenicity was marked, APS could be excluded because of a positive predictive value of 100% for IPD. Nucleus lentiformis hyperechogenicity was found in 17 of 22 (77%) APS patients but in only 5 of 22 (23%) IPD patients (Mann–Whitney U test, p < 0.001). Nucleus caudatus and thalamus echogenicity and widths of the third ventricle and of the frontal horns of the lateral ventricles did not discriminate between IPD and APS. Two patients with PSP could not be assessed because of an insufficient bone window.
Conclusions: BPS is a novel and noninvasive method to differentiate highly specifically between IPD and APS. Therefore, BPS might become a standard investigation in parkinsonian disorders.
This article has been cited by other articles:
|
|
 |
|
  J Jankovic Parkinson's disease: clinical features and diagnosis J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 368 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Walter, D. Dressler, T. Probst, A. Wolters, M. Abu-Mugheisib, M. Wittstock, and R. Benecke Transcranial Brain Sonography Findings in Discriminating Between Parkinsonism and Idiopathic Parkinson Disease Arch Neurol, November 1, 2007; 64(11): 1635 - 1640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. H. Schott, L. Niehaus, B. C. Wittmann, H. Schutze, C. I. Seidenbecher, H.-J. Heinze, and E. Duzel Ageing and early-stage Parkinson's disease affect separable neural mechanisms of mesolimbic reward processing Brain, September 1, 2007; 130(9): 2412 - 2424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Walter, J. Hoeppner, L. Prudente-Morrissey, S. Horowski, S. C. Herpertz, and R. Benecke Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders Brain, July 1, 2007; 130(7): 1799 - 1807. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kolevski, I. Petrov, and V. Petrova Transcranial Sonography in the Evaluation of Parkinson Disease J. Ultrasound Med., April 1, 2007; 26(4): 509 - 512. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Spiegel, D. Hellwig, M.-O. Mollers, S. Behnke, W. Jost, K. Fassbender, S. Samnick, U. Dillmann, G. Becker, and C.-M. Kirsch Transcranial sonography and [123I]FP-CIT SPECT disclose complementary aspects of Parkinson's disease Brain, May 1, 2006; 129(5): 1188 - 1193. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Suchowersky, S. Reich, J. Perlmutter, T. Zesiewicz, G. Gronseth, and W. J. Weiner Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Walter, K. Krolikowski, B. Tarnacka, R. Benecke, A. Czlonkowska, and D. Dressler Sonographic detection of basal ganglia lesions in asymptomatic and symptomatic Wilson disease Neurology, May 24, 2005; 64(10): 1726 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S Behnke, D Berg, M Naumann, and G Becker Differentiation of Parkinson's disease and atypical parkinsonian syndromes by transcranial ultrasound J. Neurol. Neurosurg. Psychiatry, March 1, 2005; 76(3): 423 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Walter, D. Dressler, A. Wolters, T. Probst, A. Grossmann, and R. Benecke Sonographic discrimination of corticobasal degeneration vs progressive supranuclear palsy Neurology, August 10, 2004; 63(3): 504 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V.L. Marshall, D.G. Grosset, U. Walter, R. Benecke, and D. Dressler Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes Neurology, September 23, 2003; 61(6): 871 - 871. [Full Text] [PDF]
|
|
|
|
|
|
O. Suchowersky, S. Reich, J. Perlmutter, T. Zesiewicz, G. Gronseth, and W. J. Weiner Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, April 11, 2006; 66(7): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
Read all Correspondence
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
